Godavari Biorefineries Limited (GODAVARIB) Financial Results — Revenue ₹2,000 Cr

StockFin.ai Try Free →

Revenue: ₹2,000 CrNet Profit: ₹3.5

📢 Key Event
Godavari Biorefineries reported FY26 financial results and strategic updates in earnings call

🔄 What Changed
PAT turned profitable at ₹3.5 crores; EBITDA margin expanded to 16.2% in Q4; specialty chemicals now 61% of bio-based revenue

🔮 What's Next
Grain-based distillery commissioning by June 2026; out-licensing of TNBC drug candidate within 2-3 years

💡 Investor Takeaway
Profitability recovery and specialty chemical growth signal improved margins and long-term value creation for shareholders

Godavari Biorefineries reported FY26 revenue of ₹2,000 crores (+6% YoY) and EBITDA of ₹139 crores (+15.8% YoY), returning to profitability with PAT of ₹3.5 crores after a prior loss. Q4 revenue reached ₹564 crores with EBITDA margin expanding to 16.2%. Management highlighted progress on the 200 KLPD grain-based distillery commissioning by June 2026, growth in specialty chemicals now comprising 61% of bio-based revenue, and ethanol sales of 98 million liters. Strategic focus remains on scaling high-margin specialty chemicals, advancing ethanol infrastructure, and developing R&D pipelines including a breast cancer therapy and antiviral platforms.

📄 View Original Announcement (PDF)

📊 Stock Analysis — GODAVARIB ✨ Ask AI About This